Yıldız BO,Gedik O:
Insulin resistance in polycyctic ovary syndrome; hyperandrogenemia versus normoandrogenemia. Eur J Obstet Gynecol Repord Biol 2001;100:62-66.
Tütüncü NB, Gürlek A,Gedik O:
Efficacy of ACE inhibitors and ATII receptor blockers in patients with microalbuminuria; a propective study. Acta Diabetol 2001;38:157-161.
Zileli Ş, N Adalar:
Protection of rats from the toxic effect of pituitary extract by prednisolone and trasylol. J Int Med Res 1974;2:436 -439.
Ercan N,Usman A,Koray Z:
The acute effect of somatostatin on calcitonin secretion in healthy subjects. Horm Metab Res 1993;25:281-282.
Bayraktar M,Gedik O, Akalın S:
The effect of radioactive iodine treatment on thyroid C cells. Clin Endocrinol (Oxf) 1990;33:625-630.
Bayraktar M, Van Thiel DH:
Abnormalities in measures of liver function and injury in thyroid disorders. Hepatogastroenterology 1997;44:1614-1618.
Vinik AI,Erbas T:
Neuropathy.Handbook of Exercise in Diabetes (editor-in-chief) Neil Ruderman, American Diabetes Association, 2002.
Vinik AI, Erbas T, Pfifer MA, Feldman EL, Stevens MJ, Russel JW:
Diabetic Autonomic Neuropathy. Ellenberg & Rifkin’s Diabetes Mellitus (sixth edition) (editors) Daniel Porte Jr, Robert S Sherwin, Alain Baron. Mc Graw Hill, 2002, pp:789-804.
Gurlek A, Bayraktar M, Arıyürek M:
Inappropriate reference range for peak bone mineral density in dual X-ray absorptiometry: implications for the interpretation of T-scores. Osteoporosis International ; 2000 ;11;809-813.
Gurlek A, Bayraktar M, Gedik O :
Comparision of calcitriol treatment with editronate-calcitriol and calcitonin-calcitriol combinations in Turkish women with post menopausal osteoporosis ; A prospective study. Calcified Tissue International ; 1997 ; 61 ; 39-43.